The aim of Cancer Immunology Immunotherapy is the communication of significant research documented by accurate, unambiguous data that are presented in an easily readable form. The style and quality of the journal depend to a great extent on the referees, who provide the authors with valuable criticism on the content and form of the papers submitted. These time-consuming services are provided without financial reward and are greatly appreciated. Therefore, we gratefully acknowledge the contribution in 2008 of: ...
Neu im Fachgebiet Onkologie
e.Med Kampagnen-Visual, Mail Icon II